Cargando…

Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis

BACKGROUND: Previous researches pointed out that the measurement of urine fibronectin (Fn) could be a potential diagnostic test for bladder cancer (BCa). We conducted this meta-analysis to fully assess the diagnostic value of urine Fn for BCa detection. METHODS: A systematic literature search in Pub...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Fan, Shen, Yifan, Xu, Tianyuan, Wang, Xianjin, Gao, Fengbin, Zhong, Shan, Chen, Shanwen, Shen, Zhoujun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863379/ https://www.ncbi.nlm.nih.gov/pubmed/29562940 http://dx.doi.org/10.1186/s12957-018-1358-x

Ejemplares similares

CIP2A mediates fibronectin-induced bladder cancer cell proliferation by stabilizing β-catenin
por: Gao, Fengbin, et al.
Publicado: (2017)

CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells
por: Gao, Fengbin, et al.
Publicado: (2018)

Prognostic value of site-specific metastases and therapeutic roles of surgery for patients with metastatic bladder cancer: a population-based study
por: Dong, Fan, et al.
Publicado: (2017)

Nomograms to Predict Individual Prognosis of Patients with Primary Small Cell Carcinoma of the Bladder
por: Dong, Fan, et al.
Publicado: (2018)

Dysregulation of miRNAs in bladder cancer: altered expression with aberrant biogenesis procedure
por: Dong, Fan, et al.
Publicado: (2017)

Targeting of CCN2 suppresses tumor progression and improves chemo-sensitivity in urothelial bladder cancer
por: Wang, Xiaojing, et al.
Publicado: (2017)

Risk of bladder cancer in patients with diabetes mellitus: an updated meta-analysis of 36 observational studies
por: Zhu, Zhaowei, et al.
Publicado: (2013)

Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
por: Zhu, Zhaowei, et al.
Publicado: (2013)

MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5
por: Xu, Tianyuan, et al.
Publicado: (2016)

Robotic versus Open Radical Cystectomy: An Updated Systematic Review and Meta-Analysis
por: Xia, Leilei, et al.
Publicado: (2015)

Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis
por: Zhang, Xiang, et al.
Publicado: (2016)

Urine microRNAs as biomarkers for bladder cancer: a diagnostic meta-analysis
por: Cheng, Yidong, et al.
Publicado: (2015)

Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment
por: Qin, Liang, et al.
Publicado: (2016)

Urine Micro-RNA Signature as a Potential Non-Invasive Diagnostic Biomarker in Bladder Cancer
por: Mamdouh, Samah, et al.
Publicado: (2023)

Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine
por: Lin, Jen-Tai, et al.
Publicado: (2021)

Distant metastasis without regional progression in non-muscle invasive bladder cancer: case report and pooled analysis of literature
por: Xu, Tianyuan, et al.
Publicado: (2022)

Urine Endocannabinoids as Novel Non-Invasive Biomarkers for Bladder Cancer at Early Stage
por: Vago, Riccardo, et al.
Publicado: (2020)

Inflammatory Pathways as Promising Targets to Increase Chemotherapy Response in Bladder Cancer
por: Zhu, Zhaowei, et al.
Publicado: (2012)

Combination of Urine Exosomal mRNAs and lncRNAs as Novel Diagnostic Biomarkers for Bladder Cancer
por: Huang, Haiming, et al.
Publicado: (2021)

Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer
por: Liu, Caiyun, et al.
Publicado: (2016)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent
por: Xiong, Zuquan, et al.
Publicado: (2017)

Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers
por: Ahn, Jae-Hak, et al.
Publicado: (2022)

Is APC hypermethylation a diagnostic biomarker for bladder cancer? A meta-analysis
por: Han, Wei, et al.
Publicado: (2018)

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer
por: Masuda, Norihiko, et al.
Publicado: (2018)

Urine miRNA as a potential biomarker for bladder cancer detection – a meta-analysis
por: Kutwin, Piotr, et al.
Publicado: (2018)

Urine biomarkers in ESSIC type 2 interstitial cystitis/bladder pain syndrome and overactive bladder with developing a novel diagnostic algorithm
por: Jiang, Yuan-Hong, et al.
Publicado: (2021)

Genomic profile of urine has high diagnostic sensitivity compared to cytology in non‐invasive urothelial bladder cancer
por: Hirotsu, Yosuke, et al.
Publicado: (2019)

The contemporary role and impact of urine-based biomarkers in bladder cancer
por: Duquesne, Igor, et al.
Publicado: (2017)

Urine and Serum Exosomes as Novel Biomarkers in Detection of Bladder Cancer
por: Elsharkawi, Fathia, et al.
Publicado: (2019)

Diagnostic performance of nuclear matrix protein 22 and urine cytology for bladder cancer: A meta‐analysis
por: Wang, Jie, et al.
Publicado: (2022)

Cell-Free microRNA-214 From Urine as a Biomarker for Non-Muscle-Invasive Bladder Cancer
por: Kim, Sung Min, et al.
Publicado: (2013)

Novel Non-Invasive Diagnosis of Bladder Cancer in Urine Based on Multifunctional Nanoparticles
por: Xu, Jinshan, et al.
Publicado: (2022)

The Triglycerides and Glucose Index rather than HOMA-IR is more associated with Hypogonadism in Chinese men
por: Zhang, Kun, et al.
Publicado: (2017)

Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment
por: Wong, Yien Ning Sophia, et al.
Publicado: (2018)

Urine Oxidative Stress Biomarkers as Novel Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome
por: Jiang, Yuan-Hong, et al.
Publicado: (2022)

Clinical evaluation of urine laminin‐γ2 monomer as a potent biomarker for non‐muscle invasive bladder cancer
por: Karashima, Takashi, et al.
Publicado: (2022)

Bladder Cancer Biomarker Discovery Using Global Metabolomic Profiling of Urine
por: Wittmann, Bryan M., et al.
Publicado: (2014)

Discovery of bladder cancer biomarkers in paired pre- and postoperative urine samples
por: Li, Xuechao, et al.
Publicado: (2021)

Potential urine biomarkers in bladder outlet obstruction-related detrusor underactivity
por: Jiang, Yuan-Hong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0un935t59nt247ork7dvrp7r6b